Quick Answer
LakeShore Biopharma Co., Ltd. reported Gross Profit of $70.66 million for the year ending 2025.
- LakeShore Biopharma Co., Ltd. showed a decrease of -84.5% in Gross Profit from 2024 to 2025.
- This data is from LakeShore Biopharma Co., Ltd.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), LakeShore Biopharma Co., Ltd.'s Gross Profit has declined by 64.2%.
- Historical annual values: Fiscal year 2025: $70.66 million | Fiscal year 2024: $455.73 million | Fiscal year 2023: $533.84 million | Fiscal year 2022: $385.88 million | Fiscal year 2021: $197.36 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: